Q3 2025 Management View CEO Vineet Nargolwala highlighted Q3 sales of $178 million and non-GAAP EPS of $0.07, both exceeding ...

Passenger vehicle (PV) revenues also fell by 4.3 per cent, but EBITDA margins improved by 120 basis points to 7.8 per cent, driven by cost controls and the PLI incentive ...

Brookfield real estate investment trust (REIT) reported an annual increase of 11 per cent in its net operating income (NOI) ...

Revenue increased by 9.36% YoY & profit increased by 78.17% YoY, profit at ₹31.09 crore and revenue at ₹1269.52 crore.

U.S. GDP growth slowed to 2.1% in Q4, with consumer and government spending offset by a decline in investment and rising ...

Ajanta Pharma on Thursday said its consolidated profit after tax increased by 11 per cent on-year to Rs 233 crore for the ...

American Financial Group is a mid-sized P&C insurer with strong underwriting performance and a focus on specialty lines. Read ...

In this article, we will take a look at the 12 stocks that will double in 2025.

Operator Greetings, welcome to Dynatrace fiscal third quarter 2025 earnings call. [Operator instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Noelle ...

L&T stock price has remained weak in the past one year. While L&T shares are down 3% in one month, they have fallen 8% in six months and over 4% in one year.

L&T reports 14% profit increase, Rs 1 lakh crore order inflows, strong infrastructure and energy sectors drive growth.

Phoenix Malls, Ajanta Pharma, Prestige Estates Projects, Shree Cement, Welspun Living, Vedant Fashions, Astral and Dr Lal's PathLabs will also announce results for quarter ended December.